InvestorsHub Logo
Followers 829
Posts 119605
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Tuesday, 03/08/2022 7:33:11 PM

Tuesday, March 08, 2022 7:33:11 PM

Post# of 751
Alvotech settles Humira-US-patent litigation with ABBV:

https://finance.yahoo.com/news/abbvie-resolves-humira-adalimumab-u-213200516.html

Alvotech (which is trading as OACB until the SPAC merger closes) can launch its Humira biosimilar on 7/1/23 if it has received FDA approval by then.

ABBV has now settled its US patent litigation with all Humira-biosimilar companies, as far as I know.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABBV News